Albumin as a versatile platform for drug half-life extension.
Darrell Sleep, Jason Cameron, Leslie R. Evans
Biochimica et Biophysica Acta (BBA) Volume 1830, Issue 12, December 2013, Pages 5526–5534
Pub type: VELTIS
"This article will review the mechanisms which underpin albumin's extraordinarily long circulatory half-life and how the understanding of these processes are currently being employed to extend the circulatory half-life of drugs which can be engineered to bind to albumin, or are conjugated to, or genetically fused to, albumin."